Revance Therapeutics shares owned by ProShare Advisors
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by ProShare Advisors
from 13F filings
Historical chart of ProShare Advisors investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by ProShare Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by ProShare Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $229k | 75k | 3.04 |
| 2024-09-30 | $328k | 63k | 5.19 |
| 2024-06-30 | $47k | 18k | 2.57 |
| 2024-03-31 | $108k | 22k | 4.92 |
| 2023-09-30 | $190k | 17k | 11.47 |
| 2023-06-30 | $412k | 16k | 25.31 |
| 2023-03-31 | $491k | 15k | 32.21 |
| 2022-12-31 | $317k | 17k | 18.46 |
| 2022-09-30 | $379k | 14k | 26.96 |
| 2022-06-30 | $187k | 14k | 13.81 |
| 2022-03-31 | $400k | 21k | 19.46 |
| 2021-12-31 | $414k | 25k | 16.28 |
| 2021-09-30 | $678k | 24k | 27.86 |
| 2021-06-30 | $921k | 31k | 29.65 |
| 2021-03-31 | $746k | 27k | 27.96 |
| 2020-12-31 | $686k | 24k | 28.34 |
| 2020-09-30 | $461k | 18k | 25.14 |
| 2020-06-30 | $411k | 17k | 24.41 |
| 2020-03-31 | $150k | 10k | 14.82 |
| 2019-12-31 | $258k | 16k | 16.25 |
| 2019-09-30 | $220k | 17k | 12.98 |
| 2019-06-30 | $219k | 17k | 12.96 |
| 2019-03-31 | $301k | 19k | 15.75 |
| 2018-12-31 | $322k | 16k | 20.13 |
| 2018-09-30 | $474k | 19k | 24.85 |
| 2018-06-30 | $543k | 20k | 27.45 |
| 2018-03-31 | $625k | 20k | 30.78 |
| 2017-12-31 | $717k | 20k | 35.73 |
| 2017-09-30 | $521k | 19k | 27.57 |
| 2017-06-30 | $463k | 18k | 26.43 |
| 2017-03-31 | $374k | 18k | 20.77 |
| 2016-12-31 | $458k | 22k | 20.70 |
| 2016-09-30 | $324k | 20k | 16.21 |
| 2016-06-30 | $322k | 24k | 13.59 |
| 2016-03-31 | $402k | 23k | 17.46 |
| 2015-12-31 | $862k | 25k | 34.16 |
| 2015-09-30 | $588k | 20k | 29.75 |
| 2015-06-30 | $675k | 21k | 31.98 |
| 2015-03-31 | $431k | 21k | 20.75 |
| 2014-12-31 | $297k | 18k | 16.93 |